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suppressed the secretion of TNF-~ and IL-11~ by peritoneal 
macrophages. The most potent silencing effects was 90% and 
60% suppression, respectively. Fluorescent labeled siRNA was 
found to be transduced into almost all of the cells. TNF-~ and IL- 
l I~ mRNA level of siRNA transfected synovial fibroblasts were 0.3 
fold and 0.2 fold of control cells. 
Conclusions: RNA interference (RNAi) is the powerful means 
of silencing genes, and the effect is sequence specifically. Re- 
cently, several studies applied RNAi to treat of various disorders 
in animal models, and showed that RNAi may improve promiss- 
ing strategies to treat human diseases by silencing disease- 
responsible genes in vivo. In the pathogenesis of osteoarthri- 
tis (OA) and rheumatoid arthritis (RA), various inflammatory cy- 
tokines produced by synovium leads to destruction of joints. In 
particularly, TNF-~ and IL-11~ is known as a key mediator of OA 
and RA. Therefore, to suppress the expression of TNF-~ and IL-I~ 
in joints in vivo is expected an effective and less invasive con- 
servative therapy of joint disease. In this study, TNF-~ or IL-11~ 
specific siRNA were transduced into synovial fibroblasts uccess- 
fully, and suppress the expression of TNF-~ and IL-11~ in synovial 
fibroblasts in vitro. 
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Objective: Matrix metalloprotenases (MMPs) are the most crit- 
ical proteinases to degrade the extracellular matrix of OA carti- 
lage. The objective of this study is to investigate the association 
between MMP-1 single nucleotide polymorphisms (SNPs) and 
primary knee OA progression. 
Subjects: The medical records and DNA samples were obtained 
from 418 unrelated Japanese, 115 non-OA subjects and 303 
knee symptomatic primary knee OA patients having radiographic 
grade 3 or more (mean age of 76.2 4- 8.0, 65 males and 353 fe- 
males). Non-OA population consisted of volunteers without any 
symptom and/or sign of OA who had visited these hospitals for 
fractures, injured or other orthopedic disease. Genotyping was 
performed using LightTyper and melting curve analysis. 
Results: Three SNPs were not in linkage disequilibrium. As we 
found one genotype frequency was significantly different between 
the OA progression stages, we hereafter focused on this SNP, 
1655A/G. The frequencies of AA and AG+GG group subjects in 
stage 1-2, 3 and 4 were 0.28, 0.40, 0.32 and 0.25, 0.53, 0.22, 
respectively (P= 0.0190). Age BMI, and sex ratio were not differ- 
ent significantly between these genotype groups. Therefore, we 
hypnotized that AA group subjects more likely to progress OA. 
Indeed, the medial tibiofemoral joint spaces were narrower in AA 
group subjects (adjusted to age, sex and BMI, P = 0.0158). More- 
over, this tendency was apparent in the highest tertile of BMI (> 
25.8, P= 0.0160) whereas those in the lowest and middle groups 
were not different significantly. 
Conclusion: This study suggested that one SNP in MMP1 is 
associated with knee OA severity. This SNP could be a useful 
marker to prospect the progression of knee OA. It might be bet- 
ter to recommend the patients who possess the risk genotype to 
reduce body weight for slowing the progression. Further inves- 
tigation of the molecular aspects of this SNP, or the searching 
other truly responsible SNPs may clarify the role(s) of MMP1 in 
the cartilage and the mechanisms of OA progression. 
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Aim:Patellar and femoral (trochlear) cartilage morphology can- 
not be evaluated separately on plain radiographs. Quantitative 
MR imaging, however, can provide these data with high accuracy 
and precision, but it is unclear whether it is sufficient to measure 
just the patella, or whether measurement of trochlear cartilage 
provides additional information. We therefore analyzed the corre- 
lation of patellar and trochlear cartilage morphology with quantita- 
tive MR imaging in knees with and without radiographic evidence 
of patellofemoral OA (PFOA) in a community sample. 
Methods:186 subjects from the Framingham cohort (138 women, 
48 men, age 61 4- 7.8 y) were studied. Patellar cartilage mor- 
phology was determined from axial MR images (FLASH VlBE we 
sequence, 1.5 x 0.31 x 0.31 mm 3 resolution), and trochlear car- 
tilage morphology from sagittal images, acquired with the same 
sequence. We determined total area of subchondral bone (tAB), 
percent denuded area of subchondral bone (dAB%), mean and 
maximal cartilage thickness, and cartilage volume (VC), by using 
proprietary software (Chondrometrics GmbH, Ainring, Germany). 
PFOA status was evaluated on lateral radiographs, with PFOA 
being defined as presence of osteophytes grade _> 2, or pres- 
ence of osteophytes grade _> 1 with JSN grade _> 2 in the PF 
joint. 
Results:Of 176 cases without radiographic PFOA, 18.8% dis- 
played areas of denuded cartilage in the patella (dAB% = 0-36%), 
12.5% in the trochlea (0-18%), and 5.7% in both surfaces. Of 
10 cases with PFOA, 60% displayed areas of denuded cartilage 
in the patella (0 to 57%), 80% in the trochlea (0 to 23%), and 
50% in both surfaces. Patellar cartilage thickness differed signif- 
icantly (p < 0.01) in women with (n = 9) and without PFOA (n = 
129), but interestingly trochlear cartilage did not. The correlations 
between patellar and trochlear cartilage in subjects with/without 
PFOA were r = 0.47/0.61 for tAB, r = 0.87/0.62 for VC, and r = 
0.58/0.42 for mean cartilage thickness. 
Conclusions:Denuded cartilage can be seen in a substantial 
proportion of subjects with apparently normal lateral radiographs. 
There are a number of subjects with denuded trochlear cartilage, 
who do not display denuded patellar cartilage at the same time 
(6.8% in subjects without PFOA, and 30% in subjects with PFOA). 
Also, there only exists a moderate correlation between patellar 
and trochlear cartilage morphology in subjects with and without 
radiographic PFOA, with 22% to 76% of the variability in cartilage 
morphology of the trochlea being explained by the variability in 
the patella. In summary, lateral radiographs fail to detect areas of 
full thickness cartilage loss in a considerable number of subjects. 
The results also indicate that analysis of trochlear cartilage mor- 
phology may provide unique and important information in addition 
to measurement of cartilage morphology in the patella. 
